The BioFlo Port is the first implantable port with Endexo Technology, providing a catheter material more resistant to the in-vitro accumulation of blood components compared to non-coated port catheters (based on platelet count).1.2
Endexo Technology is a permanent and non-eluting polymer that is “blended” into the polyurethane from which the catheter is made. It is present throughout the catheter including the extraluminal, intraluminal and cut catheter surface of the tip. Endexo Technology remains present for the life of the catheter and provides a catheter material more resistant to thrombus accumulation1.
Available with PASV Valve Technology, designed to resist backflow.
AngioDynamics does not provide medical advice, diagnosis, or treatment. The contents of this website, including disease state information, text, graphics, images, and other material (“Content”) are for informational purposes only. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition and the appropriate treatment for a particular medical condition.
Request a Sales Representative
Reimbursement Resources and C-Code Finder Lookup
BioFlo Port Brochure
BioFlo Port with Endexo and PASV Valve Technology Patient Guide
BioFlo Port with Endexo Patient Guide
Implantable Infusion Port Catalog
1. The reduction in thrombus accumulation (based on platelet count), is supported by acute in-vitro testing. Pre-clinical in-vitro evaluations do not necessarily predict clinical performance with respect to thrombus formation.
2. Based on benchtop testing performed up to two hours using bovine blood, which may not be indicative of clinical results. Data on file.
AngioDynamics, the AngioDynamics logo, BioFlo and PASV are trademarks of AngioDynamics, Inc., an affiliate or subsidiary. All other trademarks are property of their respective owners.
